Αποτελέσματα Αναζήτησης
Background Obesity hypoventilation syndrome (OHS) is treated with either non-invasive ventilation (NIV) or CPAP, but there are no long-term cost-effectiveness studies comparing the two treatment modalities.
20 Αυγ 2021 · This guideline covers obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS), and chronic obstructive pulmonary disease (COPD) with OSAHS overlap syndrome, providing advice on investigating and managing these related conditions.
Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity (body mass index ≥30 kg·m −2), daytime hypercapnia (arterial carbon dioxide tension ≥45 mmHg) and sleep disordered breathing, after ruling out other disorders that may cause alveolar hypoventilation.
27 Απρ 2019 · Obesity hypoventilation syndrome is commonly treated with continuous positive airway pressure or non-invasive ventilation during sleep. Non-invasive ventilation is more complex and costly than continuous positive airway pressure but might be advantageous because it provides ventilatory support.
Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive and sleep-disordered breathing. Early diagnosis and treatment is important, because ...
1 Νοε 2020 · CPAP is simpler to implement and is less costly than NIV. 24 To investigate which of the two treatments is more cost-effective, the only study reported is from Masa and cols, whom carried out a post hoc, within-trial, cost-effectiveness analysis using the large multicentre, open-labelled, randomised controlled study (Pickwick study) 3, 24, 43 ...
If the sleep evaluation demonstrates OHS and severe obstructive sleep apnea (OSA) (apnea–hypopnea index ≥ 30), the panel recommends continuous positive airway pressure (CPAP) titration and treatment.
